Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2407
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma ; volume:14 ; number:1 ; day:6 ; month:11 ; year:2014 ; pages:1-12 ; date:12.2014
BMC cancer ; 14, Heft 1 (6.11.2014), 1-12, 12.2014
- Creator
-
Wang, Yun-Hsin
- Contributor
-
Cheng, Tsung-Yen
Chen, Ta-Yuan
Chang, Kai-Ming
Chuang, Vincent P.
Kao, Kuo-Jang
SpringerLink (Online service)
- DOI
-
10.1186/1471-2407-14-815
- URN
-
urn:nbn:de:1111-2016030416416
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:23 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Wang, Yun-Hsin
- Cheng, Tsung-Yen
- Chen, Ta-Yuan
- Chang, Kai-Ming
- Chuang, Vincent P.
- Kao, Kuo-Jang
- SpringerLink (Online service)
Other Objects (12)
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan
NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment
The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets
Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan
NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment
The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets
Key therapeutic targets implicated at the early stage of hepatocellular carcinoma identified through machine-learning approaches
FXYD6: a novel therapeutic target toward hepatocellular carcinoma
Noncoding RNA as Therapeutic Targets for Hepatocellular Carcinoma
CHEK2 knockout is a therapeutic target for TP53-mutated hepatocellular carcinoma
Seminal vesicle metastasis after partial hepatectomy for hepatocellular carcinoma
Novel targets and therapeutic strategies for the treatment of hepatocellular carcinoma (HCC)
RRP8, associated with immune infiltration, is a prospective therapeutic target in hepatocellular carcinoma
Epithelial-to-mesenchymal plasticity of cancer stem cells: therapeutic targets in hepatocellular carcinoma
Advances in drug development for hepatocellular carcinoma: clinical trials and potential therapeutic targets
Current Therapeutic Strategies for Hepatocellular Carcinoma in Japan
NLRP3 inflammasome activation By 17β-estradiol is a potential therapeutic target in hepatocellular carcinoma treatment
The GH-IGF-SST system in hepatocellular carcinoma: biological and molecular pathogenetic mechanisms and therapeutic targets